PLx Pharma Winddown Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.4%.

Top 17 shareholders own 18.19% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.46%	White Rock Capital Management, L.P.	2,172,900	€399.6	0%	100.0%
4.53%	Level One Partners LLC	1,320,306	€242.8	0%	no data
4.02%	Robert Hardie	1,172,000	€215.5	0%	no data
1.7%	Michael Valentino	494,690	€91.0	0%	no data
0.15%	Steward Partners Investment Advisory, LLC	43,875	€8.1	0%	no data
0.092%	Rita O'Connor	26,670	€4.9	0%	no data
0.075%	O'Brien Greene & Co Inc	22,000	€4.0	0%	no data
0.06%	Baader Bank AG, Asset Management Arm	17,608	€3.2	0%	no data
0.022%	Osaic Wealth, Inc. , Asset Management Arm	6,550	€1.2	0%	no data
0.019%	Gary Balkema	5,445	€1.0	0%	no data
0.018%	Lord, Abbett & Co. LLC	5,200	€1.0	0%	no data
0.018%	Natasha Giordano	5,186	€1.0	0%	no data
0.013%	John Hadden	3,690	€0.7	0%	no data
0.0093%	Robert Casale	2,710	€0.5	0%	no data
0.0057%	Kirk Calhoun	1,675	€0.3	0%	no data
0.001%	Securities America Advisors, Inc.	300	€0.06	0%	no data
0.00034%	Simplex Trading, LLC, Asset Management Arm	100	€0.02	-95.7%	no data